Metástase tardia múltipla de carcinoma renal de células claras: relato de caso

Peres, Luis Alberto; Bader, Sérgio Luiz; Ferreira, José Roberto; Bueno, Alexandre Galvão; Maioli, Rafael Agostinho; Espiga, Mariana Costa; Gheller, Rafaela Aline.
J. bras. nefrol ; 31(1): 70-74, jan.-mar. 2009. ilus, tab
Artigo em Português | LILACS | ID: lil-595089

Documentos relacionados

  1. Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma.
  2. Heavy Metal Enlightens Tumor Immunity.
  3. Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
  4. Papillary Renal Cell Carcinoma: Evolving Classification by Combined Morphologic and Molecular Means.
  5. Prognostic Significance of Tumor-Associated Inflammation in Renal Cell Carcinoma.
  6. Molecular differences in renal cell carcinoma between males and females.
  7. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
  8. Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
  9. Prognostic significance of annexin A2 and tumor associated macrophages (TAMs) in metastatic renal cell carcinoma and their relation to Sunitinib resistance.
  10. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.